UBQLN2 and hepatocellular carcinoma: Here, we take advantage of two clinical trial datasets of patients with HCC who underwent surgical resection from the TCGA database and our hospital and report that Ubqln2 is highly correlated with the prognosis of HCC and a potential therapeutic target for the treatment of HCC.